CytoDyn (CYDY) Other Non Operating Income (2014 - 2025)

CytoDyn (CYDY) has 12 years of Other Non Operating Income data on file, last reported at -$7000.0 in Q2 2025.

• Quarterly Other Non Operating Income rose 99.9% year-over-year to -$7000.0 in Q2 2025, while the trailing twelve-month figure through May 2025 was -$6.9 million (up 48.15% YoY) and the FY2025 annual result came in at $400000.0, up 102.99% from the prior year.
• Other Non Operating Income eased to -$7000.0 in Q2 2025, from $327000.0 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $327000.0 in Q1 2025 to a low of -$8.1 million in Q2 2021.
• A 5-year average of -$3.3 million and a median of -$2.8 million in 2022 frame the typical range for Other Non Operating Income.
• Annual changes were most pronounced in 2021 — Other Non Operating Income plunged 159.88% — and 2025, when it jumped 121.1%.
• Tracing CYDY's Other Non Operating Income over 5 years: stood at -$3.3 million in 2021, then advanced by 6.13% to -$3.1 million in 2022, then climbed by 22.61% to -$2.4 million in 2023, then soared by 103.33% to $80000.0 in 2024, then slumped by 108.75% to -$7000.0 in 2025.
• The last three Other Non Operating Income figures came in at -$7000.0 (Q2 2025), $327000.0 (Q1 2025), and $80000.0 (Q4 2024), per Business Quant data.